Friedberg Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Friedberg Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-530	Closed	-$213K	–	102
2016 Q3	$213K	Buy	+530	New	+$213K	0.09%	95
2016 Q2	–	Sell	-580	Closed	-$209K	–	94
2016 Q1	$209K	Buy	580 +55	+10%	+$22.7K	0.1%	86
2015 Q4	$285K	Sell	525 -100	-16%	-$54.2K	0.14%	84
2015 Q3	$290K	Hold	625	–	–	0.14%	82
2015 Q2	$318K	Hold	625	–	–	0.12%	93
2015 Q1	$282K	Sell	625 -15	-2%	-$6.36K	0.1%	94
2014 Q4	$262K	Buy	+640	New	+$252K	0.1%	97

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Friedberg Investment Management's REGN Position: Q4 2016 in Review

Friedberg Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2016, closing a stake of 530 shares — an estimated $213K sold.

Friedberg Investment Management first reported a position in REGN in Q4 2014 and held it in 7 quarters. The position peaked at $318K in Q2 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

Friedberg Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Friedberg Investment Management sold 530 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $213K.
Friedberg Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 7 quarters.
Friedberg Investment Management's Regeneron Pharmaceuticals position peaked at $318K in Q2 2015.
576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on Friedberg Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.